Skip to Main content Skip to Navigation
Journal articles

Resistin-like molecule-beta inhibits SGLT-1 activity and enhances GLUT2-dependent jejunal glucose transport.: RELM-beta increases glucose absorption

Abstract : OBJECTIVE: An increased expression of RELM-beta (resistin-like molecule-beta), a gut-derived hormone, is observed in animal models of insulin resistance/obesity and intestinal inflammation. Intestinal sugar absorption is modulated by dietary environment and hormones/cytokines. The aim of this study was to investigate the effect of RELM-beta on intestinal glucose absorption. RESEARCH DESIGN AND METHODS: Oral glucose tolerance test was performed in mice and rats in the presence and the absence of RELM-beta. The RELM-beta action on glucose transport in rat jejunal sacs, everted rings, and mucosal strips was explored as well as downstream kinases modulating SGLT-1 and GLUT2 glucose transporters. RESULTS: Oral glucose tolerance test carried out in rodents showed that oral administration of RELM-beta increased glycemia. Studies in rat jejunal tissue indicated that mucosal RELM-beta promoted absorption of glucose from the gut lumen. RELM-beta had no effect on paracellular mannitol transport, suggesting a transporter-mediated transcellular mechanism. In studies with jejunal mucosa mounted in Ussing chamber, luminal RELM-beta inhibited SGLT-1 activity in line with a diminished SGLT-1 abundance in brush border membranes (BBMs). Further, the potentiating effect of RELM-beta on jejunal glucose uptake was associated with an increased abundance of GLUT2 at BBMs. The effects of RELM-beta were associated with an increased amount of protein kinase C betaII in BBMs and an increased phosphorylation of AMP-activated protein kinase (AMPK). CONCLUSIONS: The regulation of SGLT-1 and GLUT2 by RELM-beta expands the role of gut hormones in short-term AMPK/protein kinase C mediated control of energy balance.
Document type :
Journal articles
Complete list of metadatas

Cited literature [47 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00401901
Contributor : -
Submitted on : Monday, July 6, 2009 - 1:18:10 PM
Last modification on : Friday, March 27, 2020 - 3:33:39 AM
Long-term archiving on: : Tuesday, June 15, 2010 - 7:30:16 PM

Files

DB-08-1786_R2_manuscript.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Rim Belharbi Krimi, Philippe Lettéron, Pia Chedid, Corinne Nazaret, Robert Ducroc, et al.. Resistin-like molecule-beta inhibits SGLT-1 activity and enhances GLUT2-dependent jejunal glucose transport.: RELM-beta increases glucose absorption. Diabetes, American Diabetes Association, 2009, 58 (9), pp.2032-8. ⟨10.2337/db08-1786⟩. ⟨inserm-00401901⟩

Share

Metrics

Record views

379

Files downloads

1053